# Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer

> **NCT02308072** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University College, London** · enrollment: 70 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Olaparib
- **DRUG:** Cisplatin
- **RADIATION:** IMRT

## Key facts

- **NCT ID:** NCT02308072
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-09
- **Primary completion:** 2020-06
- **Final completion:** 2025-02
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-05-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02308072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02308072, "Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02308072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*